子宮頸部固定術市場：2030 年までの予測

出版：Market Research Future（マーケットリサーチフューチャー）　出版年月：2022年11月

Cervical Fusion Market Research Report – forecast till 2030
子宮頸部固定術市場調査レポート：2030 年までの予測

レポート目次　　　　お問合せ・ご注文　　　　価格・納期について

Cervical Fusion Market Research Report – forecast till 2030

Market Overview
The cervical Fusion Market is registering a CAGR of 4.72% during the forecast period. Cervical spinal fusion, otherwise called arthrodesis, is a surgery to associate bones in the cervical vertebral section of the spine underneath the neck. In the clinical areas, there are various techniques for performing cervical spinal fusion surgery wherein the most dominating is embedding a bone join for normal regrowth of the bone. Other than that, the utilization of fake units, for example, metal unions or polymer joins is likewise a substantial strategy utilized. These engineered embed joins are likewise used to keep the vertebrae intact until the development of another bone happens between them.
In view of our exploration, we have distinguished that the full-scale factors that are driving the worldwide market are the rising recurrence of cervical spondylosis among corporate specialists and the rising events of cervical wounds in vehicle mishaps. Further, the presentation of biomaterial cervical fusion inserts is another element driving the development of the cervical fusion market. In any case, then again, stresses over post-careful medicines are filling in as a smothering component for industry development. Coordinated efforts between enormous organizations and local players, then again, help the market’s allure.
Market Segment Overview
Based on Fusion Type the Global Cervical Fusion Market is classified into Anterior Interbody Fusion, Anterior Cervical Fusion, Posterior Fusion, and Others.
Based on the type segment the market is divided into Metal, Polymer, and Others.
The Surgery segment is bifurcated into Minimally Invasive Spine Surgery and Open Spine Surgery. The End User segment divides the market into Orthopedic Clinics, Multispecialty Hospitals, Neurology Clinics, and Others.
Regional Analysis
North America represented USD 882.93 million in 2021 and is supposed to show a 5.06% CAGR during the review time frame. This is credited to the developing rate of spine irregularities like scoliosis, kyphosis, and lordosis, as well as a maturing populace across the area.
Europe represents the second-biggest piece of the pie because of the accessibility of state-of-the-art treatment offices, government backing for the development of the medical services industry, a maturing populace, and an expansion in the occurrence of degenerative circle illness, rheumatoid joint pain, and osteoarthritis.
The Asia-Pacific Cervical Fusion Market is supposed to develop at a CAGR of 19.97% from 2022 to 2030. This is because of expanded paces of osteoarthritis and degenerative plate illness, the quickly developing clinical travel industry, and rising medical care costs
For example, India is inclined toward objective for clinical voyagers because of the accessibility of specialists, state-of-the-art innovation, and practical medicines.
Major Players
The key companies operating in the Cervical Fusion market are Medtronic Inc (Ireland), Abbott Laboratories (US), Stryker Corporation (US), DePuy Synthes (US), Braun Melsungen AG (Germany), NuVasive, Inc (US), Zimmer Biomet (US), Orthofix (US), and Globus Medical (US).
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

目次

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 MARKET STRUCTURE

2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 RISING PREVALENCE OF CERVICAL SPONDYLOSIS IN CORPORATE PROFESSIONALS

4.2.2 GROWING CASES OF CERVICAL INJURIES IN AUTOMOBILE CRASHES

4.3 RESTRAINT

4.3.1 CONCERNS PERTAINING TO THE POST-SURGICAL PROCEDURES

4.4 OPPORTUNITY

4.4.1 EMERGENCE OF BIOMATERIAL CERVICAL FUSION IMPLANTS

5 MARKET FACTOR ANALYSIS

5.1 SUPPLY CHAIN ANALYSIS

5.1.1 R&D AND DESIGNING

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION & SALES

5.1.4 POST-SALES MONITORING

5.2 PORTER’S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF SUBSTITUTES

5.2.4 BARGAINING POWER OF BUYERS

5.2.5 INTENSITY OF RIVALRY

6 GLOBAL CERVICAL FUSION MARKET, BY FUSION TYPE

6.1 OVERVIEW

6.2 ANTERIOR INTERBODY FUSION

6.3 ANTERIOR CERVICAL FUSION

6.4 POSTERIOR FUSION

7 GLOBAL CERVICAL FUSION MARKET, BY TYPE

7.1 OVERVIEW

7.2 METAL

7.3 POLYMER

7.4 OTHERS

8 GLOBAL CERVICAL FUSION MARKET, BY SURGERY

8.1 OVERVIEW

8.2 MINIMALLY INVASIVE SPINE SURGERY

8.3 OPEN SPINE SURGERY

9 GLOBAL CERVICAL FUSION MARKET, BY END USERS

9.1 OVERVIEW

9.2 ORTHOPAEDIC CLINICS

9.3 MULTISPECIALTY HOSPITALS

9.4 NEUROLOGY CLINICS

9.5 OTHERS

10 GLOBAL CERVICAL FUSION MARKET, BY REGION

10.1 OVERVIEW

10.2 NORTH AMERICA

10.2.1 US

10.2.2 CANADA

10.3 EUROPE

10.3.1 GERMANY

10.3.2 FRANCE

10.3.3 UK

10.3.4 ITALY

10.3.5 SPAIN

10.3.6 REST OF EUROPE

10.4 ASIA-PACIFIC

10.4.1 CHINA

10.4.2 INDIA

10.4.3 JAPAN

10.4.4 AUSTRALIA

10.4.5 SOUTH KOREA

10.4.6 REST OF ASIA-PACIFIC

10.5 REST OF THE WORLD

10.5.1 MIDDLE EAST

10.5.2 AFRICA

10.5.3 LATIN AMERICA

11 COMPETITIVE LANDSCAPE

11.1 OVERVIEW

11.2 COMPETITIVE BENCHMARKING

11.3 MAJOR GROWTH STRATEGY IN CERVICAL FUSION MARKET

11.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN CERVICAL FUSION MARKET

11.5 KEY DEVELOPMENT ANALYSIS

11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

11.6.1 PRODUCT APPROVALS AND PRODUCT LAUNCHES

11.6.2 PARTNERSHIP/COLLABORATION

11.6.3 BUSINESS EXPANSIONS/AGREEMENTS

11.6.4 MERGERS & ACQUISITIONS

11.7 MAJOR PLAYERS SALES ANALYSIS

11.7.1 SALES & OPERATING INCOME

11.8 MAJOR PLAYERS R&D ANALYSIS

12 COMPANY PROFILE

12.1 MEDTRONIC INC.

12.1.1 COMPANY OVERVIEW

12.1.2 FINANCIAL OVERVIEW

12.1.3 PRODUCTS OFFERED

12.1.4 KEY DEVELOPMENTS

12.1.5 SWOT ANALYSIS

12.1.6 KEY STRATEGIES

12.2 ABBOTT LABORATORIES

12.2.1 COMPANY OVERVIEW

12.2.2 FINANCIAL OVERVIEW

12.2.3 PRODUCTS OFFERED

12.2.4 KEY DEVELOPMENTS

12.2.5 SWOT ANALYSIS

12.2.6 KEY STRATEGIES

12.3 STRYKER CORPORATION

12.3.1 COMPANY OVERVIEW

12.3.2 FINANCIAL OVERVIEW

12.3.3 PRODUCTS/SERVICES OFFERED

12.3.4 KEY DEVELOPMENTS

12.3.5 SWOT ANALYSIS

12.3.6 KEY STRATEGIES

12.4 DEPUY SYNTHES

12.4.1 COMPANY OVERVIEW

12.4.2 FINANCIAL OVERVIEW

12.4.3 PRODUCTS OFFERED

12.4.4 KEY DEVELOPMENTS

12.4.5 SWOT ANALYSIS

12.4.6 KEY STRATEGIES

12.5 B. BRAUN MELSUNGEN AG

12.5.1 COMPANY OVERVIEW

12.5.2 FINANCIAL OVERVIEW

12.5.3 PRODUCTS/SERVICES OFFERED

12.5.4 KEY DEVELOPMENTS

12.5.5 SWOT ANALYSIS

12.5.6 KEY STRATEGIES

12.6 NUVASIVE, INC.

12.6.1 COMPANY OVERVIEW

12.6.2 FINANCIAL ANALYSIS

12.6.3 PRODUCTS/SERVICES/SOLUTIONS OFFERED

12.6.4 KEY DEVELOPMENTS

12.6.5 KEY STRATEGIES

12.7 ZIMMER BIOMET

12.7.1 COMPANY OVERVIEW

12.7.2 FINANCIAL OVERVIEW

12.7.3 PRODUCTS/SERVICES/SOLUTIONS OFFERED

12.7.4 KEY DEVELOPMENTS

12.7.5 SWOT ANALYSIS

12.7.6 KEY STRATEGIES

12.8 ORTHOFIX

12.8.1 COMPANY OVERVIEW

12.8.2 FINANCIAL OVERVIEW

12.8.3 PRODUCTS/SERVICES/SOLUTIONS 0FFERED

12.8.4 KEY DEVELOPMENTS

12.8.5 KEY STRATEGIES

12.9 GLOBUS MEDICAL

12.9.1 COMPANY OVERVIEW

12.9.2 FINANCIAL OVERVIEW

12.9.3 PRODUCTS/SERVICES/SOLUTIONS OFFERED

12.9.4 KEY DEVELOPMENTS

12.9.5 KEY STRATEGIES

13 APPENDIX

13.1 REFERENCES

13.2 RELATED REPORTS

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

TABLE 3 GLOBAL CERVICAL FUSION MARKET, BY FUSION TYPE, 2018-2030 (USD MILLION)

TABLE 4 GLOBAL CERVICAL FUSION MARKET, FOR ANTERIOR INTERBODY FUSION, BY REGION 2018-2030 (USD MILLION)

TABLE 5 GLOBAL CERVICAL FUSION MARKET, FOR FUSION TYPE, BY ANTERIOR INTERBODY FUSION, 2018-2030 (USD MILLION)

TABLE 6 GLOBAL CERVICAL FUSION MARKET, FOR ANTERIOR CERVICAL FUSION, BY REGION 2018-2030 (USD MILLION)

TABLE 7 GLOBAL CERVICAL FUSION MARKET, FOR POSTERIOR FUSION, BY REGION 2018-2030 (USD MILLION)

TABLE 8 GLOBAL CERVICAL FUSION MARKET, FOR OTHERS, BY REGION 2018-2030 (USD MILLION)

TABLE 9 GLOBAL CERVICAL FUSION MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 10 GLOBAL CERVICAL FUSION MARKET, FOR METAL, BY REGION 2018-2030 (USD MILLION)

TABLE 11 GLOBAL CERVICAL FUSION MARKET, FOR POLYMER, BY REGION 2018-2030 (USD MILLION)

TABLE 12 GLOBAL CERVICAL FUSION MARKET, FOR OTHERS, BY REGION 2018-2030 (USD MILLION)

TABLE 13 GLOBAL CERVICAL FUSION MARKET, BY SURGERY, 2018-2030 (USD MILLION)

TABLE 14 GLOBAL CERVICAL FUSION MARKET, FOR MINIMALLY INVASIVE SPINE SURGERY, BY REGION 2018-2030 (USD MILLION)

TABLE 15 GLOBAL CERVICAL FUSION MARKET, FOR OPEN SPINE SURGERY, BY REGION 2018-2030 (USD MILLION)

TABLE 16 GLOBAL CERVICAL FUSION MARKET, BY END USERS, 2018-2030 (USD MILLION)

TABLE 17 GLOBAL CERVICAL FUSION MARKET, FOR ORTHOPAEDIC CLINICS, BY REGION 2018-2030 (USD MILLION)

TABLE 18 GLOBAL CERVICAL FUSION MARKET, FOR OPEN MULTISPECIALTY HOSPITALS, BY REGION 2018-2030 (USD MILLION)

TABLE 19 GLOBAL CERVICAL FUSION MARKET, FOR OPEN NEUROLOGY CLINICS, BY REGION 2018-2030 (USD MILLION)

TABLE 20 GLOBAL CERVICAL FUSION MARKET, FOR OTHERS, BY REGION 2018-2030 (USD MILLION)

TABLE 21 GLOBAL: CERVICAL FUSION MARKET, BY REGION, 2018-2030 (USD MILLION)

TABLE 22 NORTH AMERICA: CERVICAL FUSION MARKET, BY COUNTRY, 2018-2030 (USD MILLION)

TABLE 23 NORTH AMERICA: CERVICAL FUSION MARKET, BY FUSION TYPE, 2018-2030 (USD MILLION)

TABLE 24 NORTH AMERICA: CERVICAL FUSION MARKET, FOR ANTERIOR INTERBODY FUSION, BY TYPE, 2018-2030 (USD MILLION)

TABLE 25 NORTH AMERICA: CERVICAL FUSION MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 26 NORTH AMERICA: CERVICAL FUSION MARKET, BY SURGERY, 2018-2030 (USD MILLION)

TABLE 27 NORTH AMERICA: CERVICAL FUSION MARKET, BY END USERS, 2018-2030 (USD MILLION)

TABLE 28 US: CERVICAL FUSION MARKET, BY FUSION TYPE, 2018-2030 (USD MILLION)

TABLE 29 US: CERVICAL FUSION MARKET, FOR ANTERIOR INTERBODY FUSION, BY TYPE, 2018-2030 (USD MILLION)

TABLE 30 US: CERVICAL FUSION MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 31 US: CERVICAL FUSION MARKET, BY SURGERY, 2018-2030 (USD MILLION)

TABLE 32 US: CERVICAL FUSION MARKET, BY END USERS, 2018-2030 (USD MILLION)

TABLE 33 CANADA: CERVICAL FUSION MARKET, BY FUSION TYPE, 2018-2030 (USD MILLION)

TABLE 34 CANADA: CERVICAL FUSION MARKET, FOR ANTERIOR INTERBODY FUSION, BY TYPE, 2018-2030 (USD MILLION)

TABLE 35 CANADA: CERVICAL FUSION MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 36 CANADA: CERVICAL FUSION MARKET, BY SURGERY, 2018-2030 (USD MILLION)

TABLE 37 CANADA: CERVICAL FUSION MARKET, BY END USERS, 2018-2030 (USD MILLION)

TABLE 38 EUROPE: CERVICAL FUSION MARKET, BY COUNTRY, 2018-2030 (USD MILLION)

TABLE 39 EUROPE: CERVICAL FUSION MARKET, BY FUSION TYPE, 2018-2030 (USD MILLION)

TABLE 40 EUROPE: CERVICAL FUSION MARKET, FOR ANTERIOR INTERBODY FUSION, BY TYPE, 2018-2030 (USD MILLION)

TABLE 41 EUROPE: CERVICAL FUSION MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 42 EUROPE: CERVICAL FUSION MARKET, BY SURGERY, 2018-2030 (USD MILLION)

TABLE 43 EUROPE: CERVICAL FUSION MARKET, BY END USERS, 2018-2030 (USD MILLION)

TABLE 44 GERMANY: CERVICAL FUSION MARKET, BY FUSION TYPE, 2018-2030 (USD MILLION)

TABLE 45 GERMANY: CERVICAL FUSION MARKET, FOR ANTERIOR INTERBODY FUSION, BY TYPE, 2018-2030 (USD MILLION)

TABLE 46 GERMANY: CERVICAL FUSION MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 47 GERMANY: CERVICAL FUSION MARKET, BY SURGERY, 2018-2030 (USD MILLION)

TABLE 48 GERMANY: CERVICAL FUSION MARKET, BY END USERS, 2018-2030 (USD MILLION)

TABLE 49 FRANCE: CERVICAL FUSION MARKET, BY FUSION TYPE, 2018-2030 (USD MILLION)

TABLE 50 FRANCE: CERVICAL FUSION MARKET, FOR ANTERIOR INTERBODY FUSION, BY TYPE, 2018-2030 (USD MILLION)

TABLE 51 FRANCE: CERVICAL FUSION MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 52 FRANCE: CERVICAL FUSION MARKET, BY SURGERY, 2018-2030 (USD MILLION)

TABLE 53 FRANCE: CERVICAL FUSION MARKET, BY END USERS, 2018-2030 (USD MILLION)

TABLE 54 FRANCE: CERVICAL FUSION MARKET, BY FUSION TYPE, 2018-2030 (USD MILLION)

TABLE 55 FRANCE: CERVICAL FUSION MARKET, FOR ANTERIOR INTERBODY FUSION, BY TYPE, 2018-2030 (USD MILLION)

TABLE 56 FRANCE: CERVICAL FUSION MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 57 FRANCE: CERVICAL FUSION MARKET, BY SURGERY, 2018-2030 (USD MILLION)

TABLE 58 FRANCE: CERVICAL FUSION MARKET, BY END USERS, 2018-2030 (USD MILLION)

TABLE 59 ITALY: CERVICAL FUSION MARKET, BY FUSION TYPE, 2018-2030 (USD MILLION)

TABLE 60 ITALY: CERVICAL FUSION MARKET, FOR ANTERIOR INTERBODY FUSION, BY TYPE, 2018-2030 (USD MILLION)

TABLE 61 ITALY: CERVICAL FUSION MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 62 ITALY: CERVICAL FUSION MARKET, BY SURGERY, 2018-2030 (USD MILLION)

TABLE 63 ITALY: CERVICAL FUSION MARKET, BY END USERS, 2018-2030 (USD MILLION)

TABLE 64 SPAIN: CERVICAL FUSION MARKET, BY FUSION TYPE, 2018-2030 (USD MILLION)

TABLE 65 SPAIN: CERVICAL FUSION MARKET, FOR ANTERIOR INTERBODY FUSION, BY TYPE, 2018-2030 (USD MILLION)

TABLE 66 SPAIN: CERVICAL FUSION MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 67 SPAIN: CERVICAL FUSION MARKET, BY SURGERY, 2018-2030 (USD MILLION)

TABLE 68 SPAIN: CERVICAL FUSION MARKET, BY END USERS, 2018-2030 (USD MILLION)

TABLE 69 REST OF EUORPE: CERVICAL FUSION MARKET, BY FUSION TYPE, 2018-2030 (USD MILLION)

TABLE 70 REST OF EUORPE: CERVICAL FUSION MARKET, FOR ANTERIOR INTERBODY FUSION, BY TYPE, 2018-2030 (USD MILLION)

TABLE 71 REST OF EUORPE: CERVICAL FUSION MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 72 REST OF EUORPE: CERVICAL FUSION MARKET, BY SURGERY, 2018-2030 (USD MILLION)

TABLE 73 REST OF EUORPE: CERVICAL FUSION MARKET, BY END USERS, 2018-2030 (USD MILLION)

TABLE 74 ASIA-PACIFIC: CERVICAL FUSION MARKET, BY COUNTRY, 2018-2030 (USD MILLION)

TABLE 75 ASIA-PACIFIC: CERVICAL FUSION MARKET, BY FUSION TYPE, 2018-2030 (USD MILLION)

TABLE 76 ASIA-PACIFIC: CERVICAL FUSION MARKET, FOR ANTERIOR INTERBODY FUSION, BY TYPE, 2018-2030 (USD MILLION)

TABLE 77 ASIA-PACIFIC: CERVICAL FUSION MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 78 ASIA-PACIFIC: CERVICAL FUSION MARKET, BY SURGERY, 2018-2030 (USD MILLION)

TABLE 79 ASIA-PACIFIC: CERVICAL FUSION MARKET, BY END USERS, 2018-2030 (USD MILLION)

TABLE 80 CHINA: CERVICAL FUSION MARKET, BY FUSION TYPE, 2018-2030 (USD MILLION)

TABLE 81 CHINA: CERVICAL FUSION MARKET, FOR ANTERIOR INTERBODY FUSION, BY TYPE, 2018-2030 (USD MILLION)

TABLE 82 CHINA: CERVICAL FUSION MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 83 CHINA: CERVICAL FUSION MARKET, BY SURGERY, 2018-2030 (USD MILLION)

TABLE 84 CHINA: CERVICAL FUSION MARKET, BY END USERS, 2018-2030 (USD MILLION)

TABLE 85 INDIA: CERVICAL FUSION MARKET, BY FUSION TYPE, 2018-2030 (USD MILLION)

TABLE 86 INDIA: CERVICAL FUSION MARKET, FOR ANTERIOR INTERBODY FUSION, BY TYPE, 2018-2030 (USD MILLION)

TABLE 87 INDIA: CERVICAL FUSION MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 88 INDIA: CERVICAL FUSION MARKET, BY SURGERY, 2018-2030 (USD MILLION)

TABLE 89 INDIA: CERVICAL FUSION MARKET, BY END USERS, 2018-2030 (USD MILLION)

TABLE 90 JAPAN: CERVICAL FUSION MARKET, BY FUSION TYPE, 2018-2030 (USD MILLION)

TABLE 91 JAPAN: CERVICAL FUSION MARKET, FOR ANTERIOR INTERBODY FUSION, BY TYPE, 2018-2030 (USD MILLION)

TABLE 92 JAPAN: CERVICAL FUSION MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 93 JAPAN: CERVICAL FUSION MARKET, BY SURGERY, 2018-2030 (USD MILLION)

TABLE 94 JAPAN: CERVICAL FUSION MARKET, BY END USERS, 2018-2030 (USD MILLION)

TABLE 95 AUSTRALIA: CERVICAL FUSION MARKET, BY FUSION TYPE, 2018-2030 (USD MILLION)

TABLE 96 AUSTRALIA: CERVICAL FUSION MARKET, FOR ANTERIOR INTERBODY FUSION, BY TYPE, 2018-2030 (USD MILLION)

TABLE 97 AUSTRALIA: CERVICAL FUSION MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 98 AUSTRALIA: CERVICAL FUSION MARKET, BY SURGERY, 2018-2030 (USD MILLION)

TABLE 99 AUSTRALIA: CERVICAL FUSION MARKET, BY END USERS, 2018-2030 (USD MILLION)

TABLE 100 SOUTH KOREA: CERVICAL FUSION MARKET, BY FUSION TYPE, 2018-2030 (USD MILLION)

TABLE 101 SOUTH KOREA: CERVICAL FUSION MARKET, FOR ANTERIOR INTERBODY FUSION, BY TYPE, 2018-2030 (USD MILLION)

TABLE 102 SOUTH KOREA: CERVICAL FUSION MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 103 SOUTH KOREA: CERVICAL FUSION MARKET, BY SURGERY, 2018-2030 (USD MILLION)

TABLE 104 SOUTH KOREA: CERVICAL FUSION MARKET, BY END USERS, 2018-2030 (USD MILLION)

TABLE 105 REST OF ASIA-PACIFIC: CERVICAL FUSION MARKET, BY FUSION TYPE, 2018-2030 (USD MILLION)

TABLE 106 REST OF ASIA-PACIFIC: CERVICAL FUSION MARKET, FOR ANTERIOR INTERBODY FUSION, BY TYPE, 2018-2030 (USD MILLION)

TABLE 107 REST OF ASIA-PACIFIC: CERVICAL FUSION MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 108 REST OF ASIA-PACIFIC: CERVICAL FUSION MARKET, BY SURGERY, 2018-2030 (USD MILLION)

TABLE 109 REST OF ASIA-PACIFIC: CERVICAL FUSION MARKET, BY END USERS, 2018-2030 (USD MILLION)

TABLE 110 REST OF THE WORLD: CERVICAL FUSION MARKET, BY REGION, 2018-2030 (USD MILLION)

TABLE 111 REST OF THE WORLD: CERVICAL FUSION MARKET, BY FUSION TYPE, 2018-2030 (USD MILLION)

TABLE 112 REST OF THE WORLD: CERVICAL FUSION MARKET, FOR ANTERIOR INTERBODY FUSION, BY TYPE, 2018-2030 (USD MILLION)

TABLE 113 REST OF THE WORLD: CERVICAL FUSION MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 114 REST OF THE WORLD: CERVICAL FUSION MARKET, BY SURGERY, 2018-2030 (USD MILLION)

TABLE 115 REST OF THE WORLD: CERVICAL FUSION MARKET, BY END USERS, 2018-2030 (USD MILLION)

TABLE 116 MIDDLE EAST: CERVICAL FUSION MARKET, BY FUSION TYPE, 2018-2030 (USD MILLION)

TABLE 117 MIDDLE EAST: CERVICAL FUSION MARKET, FOR ANTERIOR INTERBODY FUSION, BY TYPE, 2018-2030 (USD MILLION)

TABLE 118 MIDDLE EAST: CERVICAL FUSION MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 119 MIDDLE EAST: CERVICAL FUSION MARKET, BY SURGERY, 2018-2030 (USD MILLION)

TABLE 120 MIDDLE EAST: CERVICAL FUSION MARKET, BY END USERS, 2018-2030 (USD MILLION)

TABLE 121 AFRICA: CERVICAL FUSION MARKET, BY FUSION TYPE, 2018-2030 (USD MILLION)

TABLE 122 AFRICA: CERVICAL FUSION MARKET, FOR ANTERIOR INTERBODY FUSION, BY TYPE, 2018-2030 (USD MILLION)

TABLE 123 AFRICA: CERVICAL FUSION MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 124 AFRICA: CERVICAL FUSION MARKET, BY SURGERY, 2018-2030 (USD MILLION)

TABLE 125 AFRICA: CERVICAL FUSION MARKET, BY END USERS, 2018-2030 (USD MILLION)

TABLE 126 LATIN AMERICA: CERVICAL FUSION MARKET, BY FUSION TYPE, 2018-2030 (USD MILLION)

TABLE 127 LATIN AMERICA: CERVICAL FUSION MARKET, FOR ANTERIOR INTERBODY FUSION, BY TYPE, 2018-2030 (USD MILLION)

TABLE 128 LATIN AMERICA: CERVICAL FUSION MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 129 LATIN AMERICA: CERVICAL FUSION MARKET, BY SURGERY, 2018-2030 (USD MILLION)

TABLE 130 LATIN AMERICA: CERVICAL FUSION MARKET, BY END USERS, 2018-2030 (USD MILLION)

TABLE 131 MAJOR MANUFACTURERS IN CERVICAL FUSION MARKET

TABLE 132 MOST ACTIVE PLAYER IN CERVICAL FUSION MARKET

TABLE 133 PRODUCT APPROVALS AND PRODUCT LAUNCHES

TABLE 134 PARTNERSHIP/COLLABORATION

TABLE 135 BUSINESS EXPANSIONS/ AGREEMENTS

TABLE 136 MERGERS & ACQUISITIONS

TABLE 137 MEDTRONIC INC.: PRODUCTS OFFERED

TABLE 138 MEDTRONIC INC.: KEY DEVELOPMENTS

TABLE 139 ABBOTT LABORATORIES: PRODUCTS OFFERED

TABLE 140 STRYKER CORPORATION: PRODUCTS/SERVICES OFFERED

TABLE 141 STRYKER CORPORATION: KEY DEVELOPMENTS

TABLE 142 DEPUY SYNTHES: PRODUCTS OFFERED

TABLE 143 DEPUY SYNTHES: KEY DEVELOPMENTS

TABLE 144 B. BRAUN MELSUNGEN AG: PRODUCTS/SERVICES OFFERED

TABLE 145 NUVASIVE, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED

TABLE 146 NUVASIVE, INC.: KEY DEVELOPMENTS

TABLE 147 ZIMMER BIOMET: PRODUCTS/SERVICES/SOLUTIONS OFFERED

TABLE 148 ZIMMER BIOMET: KEY DEVELOPMENTS

TABLE 149 ORTHOFIX: PRODUCTS/SERVICES/SOLUTIONS OFFERED

TABLE 150 ORTHOFIX: KEY DEVELOPMENTS

TABLE 151 GLOBUS MEDICAL: PRODUCTS/SERVICES/SOLUTIONS OFFERED

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS

FIGURE 2 CERVICAL FUSION MARKET

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES

FIGURE 4 MARKET DYNAMICS: GLOBAL CERVICAL FUSION MARKET

FIGURE 5 DRIVERS: IMPACT ANALYSIS

FIGURE 6 RESTRAINT: IMPACT ANALYSIS

FIGURE 7 VALUE CHAIN: GLOBAL CERVICAL FUSION MARKET

FIGURE 8 PORTER’S FIVE FORCES ANALYSIS: CERVICAL FUSION MARKET

FIGURE 9 GLOBAL CERVICAL FUSION MARKET, BY FUSION TYPE, 2021 AND 2030(USD MILLION)

FIGURE 10 GLOBAL CERVICAL FUSION MARKET, BY TYPE, 2021 AND 2030(USD MILLION)

FIGURE 11 GLOBAL CERVICAL FUSION MARKET, BY SURGERY, 2021 AND 2030(USD MILLION)

FIGURE 12 GLOBAL CERVICAL FUSION MARKET, BY END USERS, 2021 AND 2030(USD MILLION)

FIGURE 13 GLOBAL: CERVICAL FUSION MARKET, BY REGION 2021 & 2030 (USD MILLION)

FIGURE 14 GLOBAL: CERVICAL FUSION MARKET SHARE (%), BY REGION, 2021

FIGURE 15 NORTH AMERICA: CERVICAL FUSION MARKET SHARE (%), BY COUNTRY 2021

FIGURE 16 EUROPE: CERVICAL FUSION MARKET SHARE (%), BY COUNTRY 2021

FIGURE 17 ASIA-PACIFIC: CERVICAL FUSION MARKET SHARE (%), BY COUNTRY 2021

FIGURE 18 REST OF THE WORLD: CERVICAL FUSION MARKET SHARE (%), BY COUNTRY 2021

FIGURE 19 BENCHMARKING OF MAJOR COMPETITORS

FIGURE 20 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN CERVICAL FUSION MARKET

FIGURE 21 CERVICAL FUSION MARKET: COMPETITIVE LANDSCAPE

FIGURE 22 MAJOR PLAYERS SALES & OPERATING INCOME, 2021

FIGURE 23 MAJOR PLAYERS R&D EXPENDITURE, 2021

FIGURE 24 MEDTRONIC INC.: FINANCIAL OVERVIEW

FIGURE 25 MEDTRONIC INC.: SWOT ANALYSIS

FIGURE 26 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 27 ABBOTT LABORATORIES: SWOT ANALYSIS

FIGURE 28 STRYKER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 STRYKER CORPORATION: SWOT ANALYSIS

FIGURE 30 DEPUY SYNTHES: SWOT ANALYSIS

FIGURE 31 B. BRAUN MELSUNGEN AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 32 B. BRAUN MELSUNGEN AG: SWOT ANALYSIS

FIGURE 33 NUVASIVE, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 34 ZIMMER BIOMET: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 35 ZIMMER BIOMET: SWOT ANALYSIS

FIGURE 36 ORTHOFIX: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 37 GLOBUS MEDICAL: FINANCIAL OVERVIEW SNAPSHOT